Sandy Cartwright

Focused on developing, analyzing, and implementing strategic, revenue streams for retail, specialty, and infusion pharmacies. Uniquely skilled with inside knowledge across specialty pharmacy operations, specialty distribution, wholesale, PBM, patient support services, manufacturer collaboration partnerships and market access. Provides leadership in business development, sales management, post launch pharmacy optimization, innovative program development and patient access initiatives to achieve revenue targets and net growth. Major accolades include:

• Territory Expansion for FL Specialty Pharmacy-Launched and organically grew Immune Globulin (IVIG) revenue line in NC to $12.5 Million annual revenue in under 2 years.
• Specialty Pharmacy Transformation of a local pharmacy into a regional specialty pharmacy, securing product access and sustainable revenue streams through strategic procurement, trade relations, and driving sales.
• Developed and launched Chronic Pain Program for Regional Specialty Pharmacy generating $2 Million revenue in first 6 months of pilot program.
• Developed and implemented Policies and Procedures in alignment with Board of Pharmacy and DEA guidelines.
• Ensured adherence to manufacturer agreements and reporting requirements.
• Drove revenues to over $5.4 Million annually in pilot area.
• Launched new Immune Globulin (IVIG) Program for local Specialty Pharmacy with growth from $3Million to over $85 Million in 3 years resulting in a 102% Compound Annual Growth Rate (CAGR).
• Negotiated, built out and managed provider-based infusion suite generating $21.2 Million in reimbursement the first year.
• Launched a pilot program for a single-line pain management therapy for local pharmacy in NC, scaling revenue to over $2 Million/month ($24 Million annually) within 18 months.
• Specialty pharmacy contracts including Home Rx, Realo Specialty Care, Prosper Infusion, Vital Care.
• Retained by Acumen Biopharma as a Consultant Expert Witness & Epidemiologist for Biopharmaceutical Antitrust Lawsuit resulting in a $25 Million settlement.

Launched Pain Management and Addiction program in new expansion territory that resulted in over $1.5M/ month in growth and new revenue.

• Nurtured manufacturer relationships to aid in business development and growth.
• Considered specialist in the field and a resource for managed care, payor formularies, drug dosing, product titration, drug conversions and patient assistance funding.

Infusion Program Developer and Sales Manager

• Developed National IVIG program including standard operating procedures, policies and procedures for infusion nursing, clinical, DME and drug management.
• Negotiated contracts with nursing and DME agencies nationally.
• Drug procurement, RFP responses, limited distribution drugs and wholesale agreement negotiations.
• Negotiate and include infusion therapies such as IVIG and factor replacement in all existing and new 340b contracts.

• Launch Gammaplex IG within Specialty Pharmacy Partners, outpatient infusion centers, 340b and private physician practice by providing product knowledge support.
• Territory expansion resulting in over 200% targeted sales goals in first two quarters.
• Managed product rollout and strategic formulary negotiation initiatives with Specialty Pharmacy Partners, PBM’s and hospitals/GPOs/IDNs.
• (1 Year Contract)

• Direct report to VP of Sales.
• Territory expansion and growing revenue stream through managing strategic relationships between Walgreens, various manufacturers, Home Infusion and Specialty Pharmacy subsidiaries.
• Exceeded target revenue with 35% year-over-year increase resulting in over $10 Million in annual revenue.

• Launch previously unmarketed Bleeding Disorder Therapy.
• Responsible for $7.5 million yearly budget with first quarter revenue attainment of 95% to plan, and by third quarter reached revenue goals of 107% to plan.
• Negotiated all aspects of Managed Care, PBM and hospital contracts/ formulary placement.

• Managed western U.S. region with team of 10 sales managers, 5 clinical nurse sales representatives and 5 patient advocate sales resource members who focused on promoting specialty and chronic biologic therapies (IVIg, Hemophilia, Pulmonary Hypertension, Enzyme Replacement).
• Managed and negotiated 340b contract with University of California San Francisco Medical Center (UCSF).
• Built and managed a $70 million yearly budget that achieved 38% over plan for 2005, 24% over plan for 2006, and 18% over plan for 2007, despite losing Blue Cross of California contract revenue due to health plan lockout.
• Awarded Presidents Club 2006 and 2007.